MedTrace Logo

P-wave Terminal Force in Patients With Atrial Fibrillation.

NCT03428971 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-01-22

No results posted yet for this study

Summary

It is suggested that P-wave terminal force (Ptf), a product of the amplitude (PAM) and the duration (PT) of the terminal phase of P-wave in lead V1, shows early delay in left atrial conduction, observed earlier that the dilatation of left atrium.

The aim is to follow PT, PAM and Ptf changes during 5-year follow-up (5FU) and examine the relation of these changes to the number of AF episodes requiring hospitalisation (HOSP) for restoration of sinus rhythm (RSR).

Conditions

Interventions

PROCEDURE

cardioversion

Direct current (DC) cardioversion for sinus rhythm restoration

Sponsors & Collaborators

  • Medical University of Lublin

    lead OTHER

Principal Investigators

  • Maciej Wójcik, MD, PhD · Medical University of Lublin, Poland

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-03-07
Completion
2020-12-07

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03428971 on ClinicalTrials.gov